Increased expression of cyclooxygenase-2 protein in 4-nitroquinoline-1-oxide-induced Rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, nimesulide

Cancer Research

Volumn 61, Issue 4, 2001, Pages 1451-1456

  Shiotani, Hiroshi ^a   Denda, Ayumi ^a   Yamamoto, Kazuhiko ^a   Kitayama, Wakashi ^a   Endoh, Takehiro ^a   Sasaki, Yasutaka ^a   Tsutsumi, Masahiro ^a   Sugimura, Masahito ^a   Konishi, Yoichi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NIMESULIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; DYSPLASIA; ENZYME ASSAY; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; WESTERN BLOTTING;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; BLOTTING, WESTERN; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; KIDNEY; LIVER; MALE; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, INBRED F344; SUBSTRATE SPECIFICITY; SULFONAMIDES; TONGUE NEOPLASMS;

EID: 0035866374     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. The epidemiology of tongue cancer: A review of global incidence
2. Oral cancer: A worldwide problem
3. Cancer of the tongue in patients younger than 40 years. A distinct entity?
4. The influence of alcohol consumption on worldwide trends in mortality from upper aerodigestive tract cancers in men
5. 13-cis-Retinoic acid in the treatment of oral leukoplakia
6. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck
7. Retinoids in cancer chemoprevention. Clinical trials with synthetic analogue fenretinide
8. Chemoprevention of oral carcinogenesis
9. Progress in cancer chemoprevention
10. Aspirin and the potential role of prostaglandins in colon cancer
11. Regulation of prostaglandin synthase-I and prostaglandin synthase-2
12. Nonsteroidal anti-inflammatory drugs and colorectal cancer: Evolving concepts of their chemopreventive actions
13. The role of cyclooxygenases in inflammation, cancer, and development
14. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
15. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis
16. Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice
17. Expression of cyclooxygenase-2 in human gastric carcinoma
18. Localization of prostaglandin H synthase isozymes in murine epidermal tumors: Suppression of skin tumor promotion by inhibition of prostaglandin H synthase-2
19. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer
20. Increased expression of cyclooxygenase-2 occurs frequently in human lung cancers, specifically in adenocarcinomas
21. Increased expression of cyclooxygenase-2 protein in rat lung tumors induced by N-nitrosobis(2- hydroxypropyl)amine
22. Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine
23. Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine
24. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
25. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck
26. A low-molecular-weight soluble protein from bovine lingual epithelium. II. Purification and characterization
27. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines
28. Definition of leukoplakia and related lesions: An aid to studies on oral precancer
29. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
30. Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy
31. Activity of nimesulide on constitutive and inducible cyclooxygenases
32. Effects of nimesulide action time dependence on selectivity towards prostaglandin G/H synthase/cyclooxygenase activity
33. Inhibitory effects of non-steroidal anti-inflammatory drugs, piroxicam and indomethacin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male ACI/N rats
34. A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells
35. Evidence for the involvement of retinoic acid receptor PARa-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis
36. Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells
37. Inhibition of cyclooxygenase-2 expression. An approach to preventing head and neck cancer
38. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells
39. Induction of cyclooxygenase-2 by activated Ha-ras oncogene in rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway
40. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins and mitogenesis in polarizing colon cancer cells
41. Elevated levels of transforming growth factor α and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer
42. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis
43. Molecular lesions in human oral cancer: The Indian scene
44. Infrequent Ha-ras mutations and absence of Ki-ras, N-ras, and p53 mutations in 4-nitroquinoline 1-oxide-induced rat oral lesions